Indian Journal of Human Genetics
REVIEW ARTICLE
Year
: 2014  |  Volume : 20  |  Issue : 2  |  Page : 101--119

Guidelines for screening, diagnosis and management of hemoglobinopathies


Kanjaksha Ghosh1, Roshan Colah1, Mamta Manglani2, Ved Prakash Choudhry3, Ishwar Verma4, Nishi Madan5, Renu Saxena6, Dipty Jain7, Neelam Marwaha8, Reena Das9, Dipika Mohanty10, Rajendra Choudhary11, Sarita Agarwal12, Malay Ghosh13, Cecil Ross14 
1 National Institute of Immunohaematology, Indian Council of Medical Research, K.E.M. Hospital, Parel, Mumbai, India
2 Department of Pediatrics and Chief, Division of Hematology-Oncology, LTMG Hospital, Mumbai, India
3 Department of Hematology, Sun Flag Hospital, New Delhi, India
4 Department of Medical Genetics, Sir Ganga Ram Hospital, New Delhi, India
5 Department of Hematology, Former Head, University College of Medical Sciences, New Delhi, India
6 Department of Hematology, AIIMS, New Delhi, India
7 Department of Pediatrics, Government Medical Hospital, Akola, Maharashtra, India
8 Department of Transfusion Medicine, PGIMER, Chandigarh, India
9 Department of Hematology, PGIMER, Chandigarh, India
10 Department of Hematology, Apollo Hospital, Bhubhaneshwar, India
11 Department of Transfusion Medicine, SGPGI, Lucknow, India
12 Department of Genetics, SGPGI, Lucknow, India
13 Department of Hematology, NRS Medical College, Kolkata, India
14 Department of Hematology, St. John's Medical College, Bangalore, Karnataka, India

Correspondence Address:
Kanjaksha Ghosh
Director, National Institute of Immunohaematology, 13th Floor, NMS Bldg, KEM Hospital Campus, Parel, Mumbai - 400 012
India

The β-thalassemias and sickle cell disorders are a major health burden in India. Diagnosis and management of these disorders both in adults and in newborns using appropriate approaches and uniform technology are important in different regions of a vast and diverse country as India. In view of a National Thalassemia Control Program to be launched soon, a need was felt for guidelines on whom to screen, cost-effective technologies that are to be used as well as for establishing prenatal diagnosis programs in regional centers. Newborn screening for sickle cell disorders is in its infancy in India and uniform approaches need to be followed. Also, included are guidelines for monitoring and managing patients who are now growing older and need comprehensive care as well as management of complications of the disease.


How to cite this article:
Ghosh K, Colah R, Manglani M, Choudhry VP, Verma I, Madan N, Saxena R, Jain D, Marwaha N, Das R, Mohanty D, Choudhary R, Agarwal S, Ghosh M, Ross C. Guidelines for screening, diagnosis and management of hemoglobinopathies.Indian J Hum Genet 2014;20:101-119


How to cite this URL:
Ghosh K, Colah R, Manglani M, Choudhry VP, Verma I, Madan N, Saxena R, Jain D, Marwaha N, Das R, Mohanty D, Choudhary R, Agarwal S, Ghosh M, Ross C. Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian J Hum Genet [serial online] 2014 [cited 2017 Mar 29 ];20:101-119
Available from: http://www.ijhg.com/article.asp?issn=0971-6866;year=2014;volume=20;issue=2;spage=101;epage=119;aulast=Ghosh;type=0